Vimarsana
Biggest News Aggregation in the World

Page 15 - Devices Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Devices Program Today - Breaking & Trending Today

VolitionRx Limited appoints DXOCRO to undertake development and clinical validation studies for its Nu.Q product portfolio in the US - Vimarsana News

VolitionRx Limited appoints DXOCRO to undertake development and clinical validation studies for its Nu.Q product portfolio in the US

VolitionRx (NYSE-A:VNRX) Limited said it has appointed Diagnostic Oncology CRO, LLC (DXOCRO) to undertake development and clinical validation studies for...

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System - Vimarsana News

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection Fraction 

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restor - Vimarsana News

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restor

Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection FractionSANTA CLARA, Calif.--(BUSINESS WIRE)--#accucinch--Ancora Heart, Inc., a company developing a novel device-based therapy to address heart...

T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme PanelMolecular Diagnostic Test for Early Detection of Lyme Disease - Vimarsana News

T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme PanelMolecular Diagnostic Test for Early Detection of Lyme Disease

T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme PanelMolecular Diagnostic Test for Early Detection of Lyme Disease - read this article along with other careers information, tips and advice on BioSpace

TGH and USF Health first in Florida to use newly developed heart implant - Vimarsana News

TGH and USF Health first in Florida to use newly developed heart implant

Tampa General is the second hospital in the country to perform the TricValve procedure and the only one to implant two patients.